| Systemic delivery of tumor-targeted Bax-derived membrane-active peptides for the treatment of melanoma tumors in a humanized SCID mouse model A Karageorgis, M Claron, R Jugé, C Aspord, F Thoreau, C Leloup, ... Molecular Therapy 25 (2), 534-546, 2017 | 21 | 2017 |
| Design of RGD–ATWLPPR peptide conjugates for the dual targeting of α V β 3 integrin and neuropilin-1 F Thoreau, L Vanwonterghem, M Henry, JL Coll, D Boturyn Organic & Biomolecular Chemistry 16 (22), 4101-4107, 2018 | 18 | 2018 |
| Synthesis and Biological Characterization of Monomeric and Tetrameric RGD‐Cryptophycin Conjugates A Borbély, F Thoreau, E Figueras, M Kadri, JL Coll, D Boturyn, N Sewald Chemistry–A European Journal 26 (12), 2602-2605, 2020 | 16 | 2020 |
| Recent, non-classical, approaches to antibody lysine modification G Chaubet, F Thoreau, A Wagner Drug Discovery Today: Technologies 30, 21-26, 2018 | 16 | 2018 |
| “Polymultivalent” Polymer–Peptide Cluster Conjugates for an Enhanced Targeting of Cells Expressing αvβ3 Integrins D Duret, A Grassin, M Henry, T Jacquet, F Thoreau, S Denis-Quanquin, ... Bioconjugate Chemistry 28 (9), 2241-2245, 2017 | 16 | 2017 |
| Modular chemical construction of IgG-like mono-and bispecific synthetic antibodies (SynAbs) F Thoreau, PA Szijj, MK Greene, LNC Rochet, IA Thanasi, JK Blayney, ... ACS Central Science 9 (3), 476-487, 2023 | 13 | 2023 |
| Multimeric RGD-based strategies for selective drug delivery to tumor tissues J Cossu, F Thoreau, D Boturyn Pharmaceutics 15 (2), 525, 2023 | 12 | 2023 |
| Enabling the formation of native mAb, Fab′ and Fc-conjugates using a bis-disulfide bridging reagent to achieve tunable payload-to-antibody ratios (PARs) F Thoreau, LNC Rochet, JR Baker, V Chudasama Chemical Science 14 (14), 3752-3762, 2023 | 6 | 2023 |
| A Novel Family of Acid-Cleavable Linker Based on Cyclic Acetal Motifs for the Production of Antibody-Drug Conjugates with High Potency and Selectivity T Rady, L Turelli, M Nothisen, E Tobaldi, S Erb, F Thoreau, ... Bioconjugate Chemistry 33 (10), 1860-1866, 2022 | 6 | 2022 |
| Enabling the next steps in cancer immunotherapy: from antibody-based bispecifics to multispecifics, with an evolving role for bioconjugation chemistry F Thoreau, V Chudasama RSC Chemical Biology 3 (2), 140-169, 2022 | 6 | 2022 |
| Combination of Targeted Therapies for Colorectal Cancer Treatment E Péraudeau, B Renoux, S Emambux, P Poinot, R Châtre, F Thoreau, ... Molecular Pharmaceutics 20 (9), 4537-4545, 2023 | 5 | 2023 |
| A novel thiol-labile cysteine protecting group for peptide synthesis based on a pyridazinedione (PD) scaffold RJ Spears, C McMahon, M Shamsabadi, C Bahou, IA Thanasi, ... Chemical Communications 58 (5), 645-648, 2022 | 5 | 2022 |
| Multimeric RGD-Based Strategies for Selective Drug Delivery to Tumor Tissues. Pharmaceutics 2023, 15, 525 J Cossu, F Thoreau, D Boturyn | | 2023 |
| Synthesis and in vitro Evaluation of Tetrameric RGD-Cryptophycin Conjugates A Borbely, F Thoreau, E Figueras, S Esposito, G Auciello, MK Dakir, ... JOURNAL OF PEPTIDE SCIENCE 24, S168-S168, 2018 | | 2018 |
| Conception, synthèse et activité biologique de vecteurs peptidiques pour le ciblage et/ou la thérapie du cancer F Thoreau Université Grenoble Alpes, 2017 | | 2017 |
| DESIGN AND SYNTHESIS OF PEPTIDE VECTORS FOR TUMORAL PERIPHERY TARGETING AND IMAGING: A TOOL FOR SURGERY. F Thoreau, M Henry, L Falcon, JL Coll, D Boturyn JOURNAL OF PEPTIDE SCIENCE 22, S216-S218, 2016 | | 2016 |
| I. Réactifs F Thoreau, D Boturyn Développement de sondes polymères fluorescentes à propriétés de ciblage …, 2016 | | 2016 |
| Cytotoxic Peptide-Drug Conjugates Based on Cryptophycins N Sewald, A Bórbely, E Figueras, A Martins, L Pethö, F Thoreau, ... The 4th Workshop on Chemistry and Biology of Microtubules and Microtubule …, 2015 | | 2015 |
| ESI: Enabling the formation of native mAb, Fab’and Fc-conjugates using a bis-disulfide bridging reagent to achieve tunable payload-to-antibody ratios (PARs) F Thoreau, LNC Rochet, JR Baker, V Chudasamaa | | |
